I agree that this site is using cookies. You can find further informations here.
X
Sarantopoulos, John
111  results:
Search for persons X
?
1

A phase 2, multicenter, open-label study of anti-LAG-3 iera..:

Lin, Chia-Chi ; Garralda, Elena ; Schöffski, Patrick...
OncoImmunology.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
2

Correction: Utilizing metformin to prevent metabolic syndro..:

Mahalingam, Devalingam ; Hanni, Salih ; Serritella, Anthony V....
Oncotarget.  14 (2023)  1 - p. 890-892 , 2023
Link: https://doi.org/10.18632..
 
?
3

Utilizing metformin to prevent metabolic syndrome due to an..:

Mahalingam, Devalingam ; Hanni, Salih ; Serritella, Anthony V....
Oncotarget.  14 (2023)  1 - p. 622-636 , 2023
Link: https://doi.org/10.18632..
 
?
4

Modulation of autophagy: a Phase II study of vorinostat plu..:

Arora, Sukeshi Patel ; Tenner, Laura ; Sarantopoulos, John...
British Journal of Cancer.  127 (2022)  6 - p. 1153-1161 , 2022
Link: https://doi.org/10.1038/..
 
?
5

ARRY-382 in Combination with Pembrolizumab in Patients with..:

Johnson, Melissa ; Dudek, Arkadiusz Z. ; Sukari, Ammar...
Clinical Cancer Research.  28 (2022)  12 - p. 2517-2526 , 2022
Link: https://doi.org/10.1158/..
 
?
6

Antitumor Activity of Lurbinectedin, a Selective Inhibitor ..:

Subbiah, Vivek ; Braña, Irene ; Longhi, Alessandra...
Clinical Cancer Research.  28 (2022)  13 - p. 2762-2770 , 2022
Link: https://doi.org/10.1158/..
 
?
7

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:

Schöffski, Patrick ; Tan, Daniel S W ; Martín, Miguel...
Journal for ImmunoTherapy of Cancer.  10 (2022)  2 - p. e003776 , 2022
Link: https://doi.org/10.1136/..
 
?
8

Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citar..:

Gordon, Michael S. ; Shapiro, Geoffrey I. ; Sarantopoulos, John...
Frontiers in Oncology.  11 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
9

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in pat..:

Tsimberidou, Apostolia-Maria ; Shaw, Jamie V. ; Juric, Dejan...
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
10

The effect of sonidegib (LDE225) on the pharmacokinetics of..:

Pooler, Darcy B. ; Ness, Dylan B. ; Sarantopoulos, John...
British Journal of Clinical Pharmacology.  87 (2020)  3 - p. 1291-1302 , 2020
Link: https://doi.org/10.1111/..
 
?
11

Antitumor activity of lurbinectedin in second-line small ce..:

Subbiah, Vivek ; Paz-Ares, Luis ; Besse, Benjamin...
Lung Cancer.  150 (2020)  - p. 90-96 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Lurbinectedin as second-line treatment for patients with sm..:

Trigo, José ; Subbiah, Vivek ; Besse, Benjamin...
The Lancet Oncology.  21 (2020)  5 - p. 645-654 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Phase I study of imalumab (BAX69), a fully human recombinan..:

Mahalingam, Devalingam ; Patel, Manish R. ; Sachdev, Jasgit C....
British Journal of Clinical Pharmacology.  86 (2020)  9 - p. 1836-1848 , 2020
Link: https://doi.org/10.1111/..
 
?
14

A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G..:

Mahalingam, Devalingam ; Peguero, Julio ; Cen, Putao...
Cancers.  11 (2019)  6 - p. 833 , 2019
Link: https://doi.org/10.3390/..
 
?
15

Pharmacokinetics of the Investigational Aurora A Kinase Inh..:

Zhou, Xiaofei ; Lockhart, A. Craig ; Fu, Siqing...
The Journal of Clinical Pharmacology.  59 (2019)  9 - p. 1204-1215 , 2019
Link: https://doi.org/10.1002/..
 
1-15